Χώρα: Ιρλανδία
Γλώσσα: Αγγλικά
Πηγή: HPRA (Health Products Regulatory Authority)
OXYCODONE HYDROCHLORIDE; Naloxone hydrochloride dihydrate
Mundipharma Pharmaceuticals Limited
N02AA; N02AA55
OXYCODONE HYDROCHLORIDE; Naloxone hydrochloride dihydrate
30/15 mg/mg
Prolonged-release tablet
Product subject to prescription which may not be renewed (A)
Natural opium alkaloids; oxycodone, combinations
Not marketed
2018-03-05
PACKAGE LEAFLET: INFORMATION FOR THE USER2.5 MG/1.25_ _MG PROLONGED-RELEASE TABLETS Διαβάστε το πλήρες έγγραφο15 MG/7.5_ _MG PROLONGED-RELEASE TABLETS 30 MG/15_ _MG PROLONGED-RELEASE TABLETS Oxycodone hydrochloride/naloxone hydrochloride READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What is and what it is used for 2. What you need to know before you take 3. How to take 4. Possible side effects 5. How to store 6. Contents of the pack and other information 1. WHAT IS AND WHAT IT IS USED FOR contains oxycodone hydrochloride and naloxone hydrochloride as active substances. is only for use in adults. is used for the treatment of severe pain, which can be adequately managed only with opioid analgesics. How works Oxycodone hydrochloride is responsible for the pain-killing effect of , and is a potent analgesic (“painkiller”) of the opioid group. The second active substance of , naloxone hydrochloride, is intended to counteract constipation. Bowel dysfunction (e.g. constipation) is a typical side effect of treatment with opioid painkillers. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE DO NOT TAKE : - if you are allergic to oxycodone hydrochloride, naloxone hydrochloride or any of the other ingredients of this medicine (listed in section 6), - if your breathing is not able to supply
Health Products Regulatory Authority 15 October 2019 CRN009DJR Page 1 of 13 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Armoneve 30 mg/15 mg prolonged-release tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each prolonged-release tablet contains 30 mg of oxycodone hydrochloride equivalent to 27 mg oxycodone and 15 mg naloxone hydrochloride as 16.48 mg of naloxone hydrochloride dihydrate equivalent to 13.5 mg naloxone Excipient with known effect: Each prolonged-release tablet contains 38.4 mg lactose monohydrate For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Prolonged-release tablet Brown, capsule shaped tablets, with a nominal length of 9.5 mmand with a film coating, embossed “OXN” on one side and “30” on the other. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Severe pain, which can be adequately managed only with opioid analgesics. The opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut. Armoneve is indicated in adults. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The analgesic efficacy of Armoneve is equivalent to oxycodone hydrochloride prolonged-release formulations. The dosage should be adjusted to the intensity of pain and the sensitivity of the individual patient. Armoneve should be administered as follows: _Adults _ The usual starting dose for an opioid naïve patient is 10 mg/5 mg of oxycodone hydrochloride/naloxone hydrochloride at 12 hourly intervals. Lower strengths are available to facilitate dose titration when initiating opioid therapy and for individual dose adjustment. Patients already receiving opioids may be started on higher doses depending on their previous opioid experience. The maximum daily dose is 160 mg oxycodone hydrochloride and 80 mg naloxone hydrochloride. The maximum daily dose is reserved for patients who have previously been maintained on a stable daily dose and who have become in need of an increased dose. Spec Διαβάστε το πλήρες έγγραφο